CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Apyx Investors of a Lead Plaintiff Deadline of August 5, 2022

NEW YORK, July 18, 2022

The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors who purchased between May 12, 2021 and March 11, 2022.

If you suffered a loss on your investment in Apyx, contact us about potential recovery by using the link below. There is no cost or obligation to you.

https://www.wongesq.com/pslra-1/apyx-medical-corporation-loss-submission-form-2?prid=29878&wire=4

ABOUT THE ACTION: The class action against Apyx includes allegations that the Company made materially false and/or misleading statements and/or failed to disclose that: (1) a significant number of Apyx's Advanced Energy products were used for off-label indications; (2) such off-label uses led to an increase in the number of medical device reports filed by Apyx reporting serious adverse events; (3) as a result, the Company was reasonably likely to incur regulatory scrutiny; (4) as a result of the foregoing, the Company's financial results would be adversely impacted; and (5) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

DEADLINE: August 5, 2022

Aggrieved Apyx investors only have until August 5, 2022 to request that the Court appoint you as lead plaintiff. You are not required to act as a lead plaintiff in order to share in any recovery.